Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/251085
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver |
Autor: | Varan, Gamze; Akkin, Safiye; Demirtürk, Nurbanu; Benito, Juan M. CSIC ORCID CVN ; Bilensoy, Erem | Palabras clave: | 3D multicellular spheroid Amphiphilic cyclodextrin Cholesterol Erlotinib nanoparticle Hepatocellular carcinoma Non-small cell lung carcinoma |
Fecha de publicación: | 2021 | Editor: | Taylor & Francis | Citación: | Journal of Drug Targeting 29: 439- 453 (2021) | Resumen: | Erlotinib (ERL), a tyrosine kinase inhibitor approved for therapeutic use in non-small cell lung cancer is further researched for eventual liver cancer treatment. However, conventional ERL has important bioavailability problems resulting from oral administration, poor solubility and gastrointestinal degradation into inactive metabolites. Alternative administration routes and nanoparticulate drug delivery systems are studied to prevent or reduce these drawbacks. In this study, ERL-loaded CD nanosphere and nanocapsule formulations capable of cholesterol depletion in resistant cancer cells were evaluated for ERL delivery. Drug loading and release profile depended largely on the surface charge of nanoparticles. Antiproliferative activity data obtained from 2D and 3D cell culture models demonstrated that polycationic ßCD nanocapsules were the most effective formulation for ERL delivery to lung and liver cancer cells. 3D tumour tumoral penetration studies further revealed that nanocapsule formulations penetrated deeper into the tumour through the multilayered cells. Furthermore, all formulations were able to extract membrane cholesterol from lung and liver cancer cell lines, indicating the induction of apoptosis and overcoming drug resistance. In conclusion, given their tumoral penetration and cell membrane cholesterol depletion abilities, amphiphilic CD nanocapsules emerge as promising alternatives to improve the safety and efficiency of ERL treatment of both liver and lung tumours. | Versión del editor: | http://dx.doi.org/10.1080/1061186X.2020.1853743 | URI: | http://hdl.handle.net/10261/251085 | DOI: | 10.1080/1061186X.2020.1853743 | Identificadores: | doi: 10.1080/1061186X.2020.1853743 issn: 1029-2330 |
Aparece en las colecciones: | (IIQ) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
JDT-2020-OR-0382_P.pdf | 1,58 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
61
checked on 23-abr-2024
Download(s)
474
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.